实验药物将胆固醇“硫酸盐”分解93.9%,为心脏病带来新的希望。 Experimental drug slashes "stealthy" cholesterol by 93.9%, offering new hope for heart disease.

在一次开创性试验中,一剂实验药物几乎消除了被称为脂质蛋白(a)的“硫酸盐”胆固醇,6个月后将水平降低了93.9%。 In a groundbreaking trial, a single dose of an experimental drug nearly eliminated "stealthy" cholesterol, known as lipoprotein(a), reducing levels by 93.9% after six months. 这种胆固醇形式往往对目前的治疗有抗药性,并且与心脏病和中风风险较高有关。 This form of cholesterol is often resistant to current treatments and is linked to higher risks of heart disease and stroke. 这些大有希望的结果,即使一年后也显示出持续的影响,可能会使胆固醇管理发生革命性变化,给胆固醇含量高的数百万人带来希望。 The promising results, showing sustained effects even after a year, could revolutionize cholesterol management and offer hope to millions with high cholesterol levels.